SCHEMBL5787761

SCHEMBL5787761

CCC(NC(=O)CCCC#N)c1cc2onc(C)c2c(=O)n1Cc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.38
CTSB P07858 1/20 0.35
ALDH1A1 P00352 6/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
SAE1 Q9UBE0 1/20 0.35
UBA2 Q9UBT2 1/20 0.35
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.33
DCTPP1 Q9H773 1/20 0.33
TAS2R8 Q9NYW2 1/20 0.33
PPARG P37231 1/20 0.32
MAPT P10636 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5787902 0.85 KIF11 (0.35) KIF11ALDH1A1HPGDHTTSAE1
SCHEMBL5790994 0.85 KIF11 (0.36) KIF11ALDH1A1HPGDHTTSAE1
SCHEMBL5787757 0.84 KIF11 (0.51) KIF11HPGDPOLBSMN1; SMN2LMNA
SCHEMBL5784700 0.76 KIF11 (0.40) KIF11ALDH1A1HPGDHTTSAE1
SCHEMBL5899045 0.74 KIF11 (0.51) KIF11ALDH1A1HPGDHTTSAE1
SCHEMBL5787320 0.74 KIF11 (0.51) KIF11
SCHEMBL5789734 0.73 KIF11 (0.42) KIF11
SCHEMBL5790138 0.73 KIF11 (0.45) KIF11ALDH1A1GAALMNA
SCHEMBL5785400 0.72 KIF11 (0.49) KIF11
SCHEMBL5899038 0.71 KIF11 (0.47) KIF11POLBSMN1; SMN2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628981-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2006-03-01 EP disclosed
WO-2004106492-A2 BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-09 WO disclosed